Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VRCA | Verrica Pharmaceuticals Inc. | Director | $4.54M | Jul 5, 2022 | ||
TSHA | Taysha Gene Therapies, Inc. | Director | $2.99M | May 29, 2024 | ||
ABOS | Acumen Pharmaceuticals, Inc. | Director | Jun 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|